Tags Uncategorized Novartis Announces Drug Approval for Treatment of Diabetic Macular Edema 3 years ago
Tags Medical Affairs REGENXBIO Starts Second Pivotal Trial in RGX-314 for the Subretinal Delivery Treatment of Wet AMD 3 years ago
